title: LRRTM3 Gene
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | LRRTM3 |
| Full Name | Leucine-Rich Repeat Transmembrane Neuronal 3 |
| Chr Location | 10q21.3 |
| NCBI Gene ID | 285220 |
| OMIM ID | 611242 |
| Ensembl ID | ENSG00000163220 |
| UniProt ID | Q86VH5 |
| Encoded Protein | LRRTM3 |
| Associated Diseases | Alzheimer's disease, autism spectrum disorder, visual processing disorders, bipolar disorder |
</div>
LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3) is a synaptic adhesion molecule that plays a critical role in excitatory synapse formation and function. Located on chromosome 10q21.3, LRRTM3 is a member of the LRRTM family of leucine-rich repeat transmembrane proteins that regulate synaptic development in the central nervous system. LRRTM3 has distinct binding properties compared to other LRRTM family members and has specialized functions in specific neural circuits, particularly in the hippocampus and visual pathway.
The gene has garnered significant attention in neurodegenerative research due to its genetic association with late-onset Alzheimer's disease (LOAD) and its role in regulating amyloid precursor protein (APP) processing.[@lincoln2013] Additionally, rare genetic variants in LRRTM[@dutta2023]3 have been implicated in autism spectrum disorder (ASD) and bipolar disorder, highlighting its importance in synaptic function and neurological disease pathogenesis [1][2][3].
title: LRRTM3 Gene
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | LRRTM3 |
| Full Name | Leucine-Rich Repeat Transmembrane Neuronal 3 |
| Chr Location | 10q21.3 |
| NCBI Gene ID | 285220 |
| OMIM ID | 611242 |
| Ensembl ID | ENSG00000163220 |
| UniProt ID | Q86VH5 |
| Encoded Protein | LRRTM3 |
| Associated Diseases | Alzheimer's disease, autism spectrum disorder, visual processing disorders, bipolar disorder |
</div>
LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3) is a synaptic adhesion molecule that plays a critical role in excitatory synapse formation and function. Located on chromosome 10q21.3, LRRTM3 is a member of the LRRTM family of leucine-rich repeat transmembrane proteins that regulate synaptic development in the central nervous system. LRRTM3 has distinct binding properties compared to other LRRTM family members and has specialized functions in specific neural circuits, particularly in the hippocampus and visual pathway.
The gene has garnered significant attention in neurodegenerative research due to its genetic association with late-onset Alzheimer's disease (LOAD) and its role in regulating amyloid precursor protein (APP) processing.[@lincoln2013] Additionally, rare genetic variants in LRRTM[@dutta2023]3 have been implicated in autism spectrum disorder (ASD) and bipolar disorder, highlighting its importance in synaptic function and neurological disease pathogenesis [1][2][3].
LRRTM3 encodes a type I transmembrane protein with a distinct domain structure that mediates its synaptic functions:
Multiple LRRTM3 isoforms have been identified, with the canonical isoform encoding a 523-amino acid protein. Alternative splicing generates variants with different extracellular domain configurations, potentially affecting ligand binding specificity.[@um2016] The splice variants exhibit differential expression patterns across brain regions, suggesting tissue-specific regulation of LRRTM3 function [2][10].
LRRTM3 is a key organizer of excitatory synapses, functioning through both presynaptic and postsynaptic mechanisms. Unlike other LRRTM family members, LRRTM3 exhibits unique binding properties that enable specialized roles in specific neural circuits.
Postsynaptic Mechanisms:
LRRTM3 plays a crucial role in regulating activity-dependent synchronization of synapse properties in topographically connected hippocampal neural circuits [1]. The gene regulates:
Recent work by Lee et al. (2026) revealed that LRRTM3 enables juvenile-to-adult refinement of thalamic reticular circuits, which is critical for high-resolution sensory encoding [8]. This finding establishes LRRTM3 as a key regulator of sensory processing circuitry maturation.
LRRTM3 is highly expressed in visual processing regions and contributes to retinogeniculate connectivity. The protein's role in visual circuit development may explain its association with visual processing disorders [9].
LRRTM3 was originally identified as a positional candidate gene for late-onset Alzheimer's disease through genetic linkage studies. Initial studies by Majercak et al. (2006) demonstrated that LRRTM3 promotes processing of amyloid precursor protein (APP) by beta-secretase (BACE1), positioning it at the intersection of amyloidogenesis and synaptic function [5].
Follow-up research by Lincoln et al. (2013) confirmed that LRRTM3 interacts with both APP and BACE1, and identified genetic variants in LRRTM3 that associate with late-onset Alzheimer's disease [4]. These findings suggest that LRRTM3 may influence AD risk through its effects on amyloid-beta production.
LRRTM3 regulates APP metabolism through multiple mechanisms:
Despite initial evidence suggesting LRRTM3 promotes amyloid-beta production, studies in knock-out mice showed that LRRTM3 is dispensable for amyloid-beta production in vivo [9]. This suggests that compensatory mechanisms may exist, or that LRRTM3's role in AD is more complex than initially hypothesized.
The synaptic dysfunction observed in Alzheimer's disease may involve LRRTM3 through several mechanisms:
Dutta et al. (2023) identified specific LRRTM3 genetic variants (rs1925575 and rs1925608) that contribute to autism spectrum disorder trait severity [3]. These findings support a role for LRRTM3 in synaptic dysfunction mechanisms underlying ASD.
LRRTM3's role in synapse formation and function directly aligns with the synaptic dysfunction hypothesis of autism. The protein's ability to organize excitatory synapses through neurexin and PTPσ binding may be particularly relevant to ASD pathogenesis [4][7].
Targeted sequencing of the LRRTM gene family in suicide attempters with bipolar disorder identified rare variants in LRRTM3, suggesting potential involvement in mood disorder pathophysiology [11]. This connection may relate to synaptic dysfunction in mood disorders.
LRRTM3 exhibits region-specific expression in the central nervous system:
LRRTM3 expression peaks during early postnatal development (P7-P21 in mice), corresponding to the critical period of synapse formation and circuit refinement. Expression decreases in adulthood but remains elevated in regions undergoing continuous synaptic plasticity [10].
LRRTM3 binds to presynaptic neurexin proteins through its LRR domain. This binding is:
LRRTM3 interacts with the receptor-type protein tyrosine phosphatase PTPσ (PTPRS), providing a postsynaptic signaling mechanism for synapse organization [4].
LRRTM3 physically interacts with:
The LRRTM (Leucine-Rich Repeat Transmembrane Neuronal) family consists of four members [3][15]:
| Gene | Chromosome | Expression Pattern | Key Functions |
|------|-------------|-------------------|---------------|
| LRRTM1 | 2p21 | Cortex, hippocampus | Synapse formation, sociability |
| LRRTM2 | 5q31.3 | Broad CNS expression | Excitatory synaptogenesis |
| LRRTM3 | 10q21.3 | Hippocampus, visual cortex | Circuit-specific function |
| LRRTM4 | 12p12.3 | Cortex, cerebellum | AMPAR trafficking |
Each LRRTM has distinct binding properties and functions [14]:
LRRTM1: Known for social behavior; rare variants associated with autism LRRTM2: Most broadly expressed; canonical excitatory synaptogenesis LRRTM3: Specialized in specific circuits; visual system function LRRTM4: Enriched in cerebellum; motor learning involvement
LRRTMs differ in their neurexin splice site preferences [2]:
Each LRRTM activates distinct intracellular pathways:
| LRRTM | Primary Signaling | Synaptic Effect |
|-------|-------------------|-----------------|
| LRRTM1 | PSD-95 recruitment | Social behavior modulation |
| LRRTM2 | AMPAR recruitment | General synaptogenesis |
| LRRTM3 | Activity-dependent plasticity | Circuit refinement |
| LRRTM4 | Cerebellar pathways | Motor learning |
LRRTM3 interacts with APP and BACE1 through distinct domains [4][5]:
APP Interaction Interface: Cytoplasmic tail binds APP intracellular domain, enabling potential bidirectional signaling and influencing APP trafficking.
BACE1 Colocalization: Accumulates in synaptic compartments with BACE1, potentially regulating BACE1 activity locally and providing spatial regulation of amyloidogenesis.
Multiple studies support LRRTM3 in AD risk [4][5]:
Despite complexity, LRRTM3 offers therapeutic opportunities:
LRRTM3 organizes the postsynaptic density [1][2]:
LRRTM3 can induce presynaptic specialization [3]:
Recent work reveals LRRTM3 function in circuit refinement [1]:
LRRTM3 is essential for visual pathway formation [16]:
Dysregulation may contribute to:
LRRTM3 represents a potential therapeutic target for:
The LRRTM gene family emerged through duplication events [10]:
| Species | LRRTM3 Homolog | Amino Acid Identity |
|---------|-----------------|---------------------|
| Human | LRRTM3 | 100% |
| Mouse | Lrrtm3 | 96% |
| Rat | Lrrtm3 | 95% |
| Chicken | LRRTM3 | 88% |
| Zebrafish | lrrtm3 | 72% |
| Frog | lrrtm3 | 75% |
Key functional domains are highly conserved:
The leucine-rich repeat (LRR) domain forms a characteristic solenoid structure:
LRRTM3-neurexin binding involves:
LRRTM3 variants contribute to multiple conditions:
The AD connection remains complex:
LRRTM3 as a drug target:
| Approach | Advantages | Challenges |
|----------|------------|-------------|
| Agonist antibodies | High specificity | Delivery to brain |
| Peptide mimetics | Cell penetration | Stability |
| Gene therapy | Long-term effect | Viral delivery |
| Small molecules | Oral bioavailability | Target specificity |